What are the major opportunities in the Eosinophilic Asthma market? What are the strategies for the Eosinophilic Asthma market?

For detailed insights on the major opportunities and strategies in the Eosinophilic Asthma market, Read More

How does the Eosinophilic Asthma market relate to the overall economy and other similar markets?

For detailed insights on the key dynamics influencing the Eosinophilic Asthma market growth and SWOT analysis of the Eosinophilic Asthma industry, Read More

For detailed insights on the mergers and acquisitions in the Eosinophilic Asthma industry,

What are the key dynamics influencing the Eosinophilic Asthma market growth? SWOT analysis of the Eosinophilic Asthma market. Read More

Global Eosinophilic Asthma Market Report 2025

Item added to cart!

Report Price : $4490.00

Pages : 175

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF

Purchase This Report

Eosinophilic Asthma Global Market Report 2025

Name: Eosinophilic Asthma Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Disease (Severe Eoisnophilic Asthma, Mild To Moderate Eosinophilic Asthma), By Treatment (Biologics, Bronchodilators, Corticosteroids, Immunomodulators, Other Treatments), By End User (Hospitals, Clinics, Other End Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Eosinophilic Asthma Market Overview

• Eosinophilic Asthma market size has reached to $2.69 billion in 2024

• Expected to grow to $5.95 billion in 2029 at a compound annual growth rate (CAGR) of 17.1%

• Growth Driver: Impact Of Rising Smoking Habits On The Growth Of The Market

• Market Trend: Advancements In Targeted Therapies For Severe Asthma Management

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Eosinophilic Asthma Market?

Eosinophilic asthma is a form of asthma where high eosinophil counts, a specific white blood cell type, cause airway inflammation. This condition results in severe symptoms such as breathing issues and recurring flare-ups, with limited effectiveness from standard treatments such as inhaled steroids.

The main diseases types in the eosinophilic asthma are severe eosinophilic asthma and mild to moderate eosinophilic asthma. Severe eosinophilic asthma is a severe variant of asthma marked by elevated levels of eosinophils, a type of white blood cell that plays a role in airway inflammation. Treatment options include biologics, bronchodilators, corticosteroids, Immunomodulators, and other therapies. These treatments are used in hospitals, clinics, and other healthcare settings.

Eosinophilic Asthma Market Size and growth rate 2025 to 2029: Graph

What Is The Eosinophilic Asthma Market Size 2025 And Growth Rate?

What Is The Eosinophilic Asthma Market Growth Forecast?

The eosinophilic asthma market size is expected to see rapid growth in the next few years. It will grow to $5.95 billion in 2029 at a compound annual growth rate (CAGR) of 17.1%. The growth in the forecast period can be attributed to increasing prevalence of respiratory diseases, rising awareness and diagnosis rates, expanding therapeutic indications for monoclonal antibodies, growing investment in healthcare infrastructure, and the rising personalized medicine approaches. Major trends in the forecast period include development of targeted biologics, improved diagnostic tools, personalized treatment approaches, enhanced drug delivery systems, integration of digital health technologies, and expanded clinical trials for novel therapies.

The forecast of 17.1% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may pose a significant challenge for the U.S. by restricting access to biologic therapies imported from Switzerland and the UK, potentially worsening severe asthma control and increasing pulmonology treatment costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Eosinophilic Asthma Market Segmented?

1) By Disease: Severe Eoisnophilic Asthma, Mild To Moderate Eosinophilic Asthma

2) By Treatment: Biologics, Bronchodilators, Corticosteroids, Immunomodulators, Other Treatments

3) By End User: Hospitals, Clinics, Other End Users

Subsegments:

1) By Severe Eosinophilic Asthma: Refractory Eosinophilic Asthma, Late-Onset Eosinophilic Asthma

2) By Mild To Moderate Eosinophilic Asthma: Early-Onset Eosinophilic Asthma, Intermittent Eosinophilic Asthma

What Is Driving The Eosinophilic Asthma Market? Impact Of Rising Smoking Habits On The Growth Of The Market

The rising smoking habits is expected to propel the growth of the eosinophilic asthma market going forward. Smoking habits refer to the regular behaviors or patterns of using tobacco products, such as the frequency, context, and duration of smoking, often influenced by psychological, social, and environmental factors. The rising smoking habits are due to factors such as increased stress levels, targeted marketing by tobacco companies, lack of awareness about health risks, and social acceptance of smoking in certain cultures. Eosinophilic asthma treatment helps reduce airway inflammation and improve lung function, which can encourage smoking cessation by alleviating the respiratory issues that often drive patients to continue smoking. For instance, in December 2023, according to the National Health Service, a UK-based government department, there were an estimated 408,700 hospital admissions due to smoking in 2022–23 from 389,800 in 2021–22, representing an increase of 4.8%. Therefore, the rising smoking rates drives the eosinophilic asthma industry.

Who Are The Major Players In The Global Eosinophilic Asthma Market?

Major companies operating in the eosinophilic asthma market are Roche Holding AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Novartis AG, GSK plc, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Limited, Boehringer Ingelheim GmbH, Regeneron Pharmaceuticals Inc., Chiesi Farmaceutici S.p.A.

What Are The Key Trends Of The Global Eosinophilic Asthma Market? Advancements In Targeted Therapies For Severe Asthma Management

Major companies operating in the eosinophilic asthma market are developing innovative drugs, to target specific immune pathways, reduce inflammation, and improve patient outcomes through personalized treatment options. A monoclonal antibody is a type of laboratory-made molecule that can mimic the immune system's ability to fight off harmful pathogens such as viruses and bacteria that are created through a process involving the fusion of a specific antibody-producing cell with a cancer cell, allowing the production of large quantities of identical antibodies. For instance, in August 2024, AstraZeneca plc, a UK-based biopharmaceutical company announced Fasenra approved by the China's National Medical Products Association, a China-based government agency for the treatment of severe eosinophilic asthma. It is specifically indicated for patients with severe eosinophilic asthma, a condition characterized by high levels of eosinophils, which can lead to inflammation and worsening asthma symptoms. It is a monoclonal antibody that targets and depletes eosinophils through a unique mechanism. Fasenra enhances the immune system's ability by binding to the IL-5 receptor on eosinophils, to reduce eosinophil levels in the blood and tissues. The dosing regimen involves an initial loading phase followed by maintenance doses. Patients usually receive injections every four weeks for the first three doses, followed by every eight weeks thereafter.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Eosinophilic Asthma Market? Strategic Acquisition Enhances Respiratory Portfolio And Expands Patient Reach

In February 2024, GSK plc, a UK-based biopharmaceutical company, acquired Aiolos Bio for $1 billion. With this acquisition, GSK aims to boost its respiratory portfolio by targeting severe asthma patients with low T2 inflammation and expand its market reach and leadership in respiratory therapies while addressing a broader spectrum of asthma patients. Aiolos Bio is a US based biotechnology company specializes in developing treatments for respiratory and inflammatory conditions including eosinophilic asthma.

What Is The Regional Outlook For The Global Eosinophilic Asthma Market?

North America was the largest region in the eosinophilic asthma market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Eosinophilic Asthma Market?

The eosinophilic asthma market consists of sales of mepolizuma and benralizumab. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Eosinophilic Asthma Industry?

The eosinophilic asthma market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the eosinophilic asthma industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Eosinophilic Asthma Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$3.16 billion
Revenue Forecast In 2034	$5.95 billion
Growth Rate	CAGR of 17.1% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The eosinophilic asthma market covered in this report is segmented – 1) By Disease: Severe Eoisnophilic Asthma, Mild To Moderate Eosinophilic Asthma 2) By Treatment: Biologics, Bronchodilators, Corticosteroids, Immunomodulators, Other Treatments 3) By End User: Hospitals, Clinics, Other End Users Subsegments: 1) By Severe Eosinophilic Asthma: Refractory Eosinophilic Asthma, Late-Onset Eosinophilic Asthma 2) By Mild To Moderate Eosinophilic Asthma: Early-Onset Eosinophilic Asthma, Intermittent Eosinophilic Asthma
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Roche Holding AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Novartis AG, GSK plc, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Limited, Boehringer Ingelheim GmbH, Regeneron Pharmaceuticals Inc., Chiesi Farmaceutici S.p.A.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Eosinophilic Asthma Market Characteristics

3. Eosinophilic Asthma Market Trends And Strategies

4. Eosinophilic Asthma Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Eosinophilic Asthma Growth Analysis And Strategic Analysis Framework

5.1. Global Eosinophilic Asthma PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Eosinophilic Asthma Market Growth Rate Analysis

5.4. Global Eosinophilic Asthma Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Eosinophilic Asthma Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Eosinophilic Asthma Total Addressable Market (TAM)

6. Eosinophilic Asthma Market Segmentation

6.1. Global Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Severe Eoisnophilic Asthma

Mild To Moderate Eosinophilic Asthma

6.2. Global Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Biologics

Bronchodilators

Corticosteroids

Immunomodulators

Other Treatments

6.3. Global Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Clinics

Other End Users

6.4. Global Eosinophilic Asthma Market, Sub-Segmentation Of Severe Eosinophilic Asthma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Refractory Eosinophilic Asthma

Late-Onset Eosinophilic Asthma

6.5. Global Eosinophilic Asthma Market, Sub-Segmentation Of Mild To Moderate Eosinophilic Asthma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Early-Onset Eosinophilic Asthma

Intermittent Eosinophilic Asthma

7. Eosinophilic Asthma Market Regional And Country Analysis

7.1. Global Eosinophilic Asthma Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Eosinophilic Asthma Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Eosinophilic Asthma Market

8.1. Asia-Pacific Eosinophilic Asthma Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Eosinophilic Asthma Market

9.1. China Eosinophilic Asthma Market Overview

9.2. China Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Eosinophilic Asthma Market

10.1. India Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Eosinophilic Asthma Market

11.1. Japan Eosinophilic Asthma Market Overview

11.2. Japan Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Eosinophilic Asthma Market

12.1. Australia Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Eosinophilic Asthma Market

13.1. Indonesia Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Eosinophilic Asthma Market

14.1. South Korea Eosinophilic Asthma Market Overview

14.2. South Korea Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Eosinophilic Asthma Market

15.1. Western Europe Eosinophilic Asthma Market Overview

15.2. Western Europe Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Eosinophilic Asthma Market

16.1. UK Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Eosinophilic Asthma Market

17.1. Germany Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Eosinophilic Asthma Market

18.1. France Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Eosinophilic Asthma Market

19.1. Italy Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Eosinophilic Asthma Market

20.1. Spain Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Eosinophilic Asthma Market

21.1. Eastern Europe Eosinophilic Asthma Market Overview

21.2. Eastern Europe Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Eosinophilic Asthma Market

22.1. Russia Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Eosinophilic Asthma Market

23.1. North America Eosinophilic Asthma Market Overview

23.2. North America Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Eosinophilic Asthma Market

24.1. USA Eosinophilic Asthma Market Overview

24.2. USA Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Eosinophilic Asthma Market

25.1. Canada Eosinophilic Asthma Market Overview

25.2. Canada Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Eosinophilic Asthma Market

26.1. South America Eosinophilic Asthma Market Overview

26.2. South America Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Eosinophilic Asthma Market

27.1. Brazil Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Eosinophilic Asthma Market

28.1. Middle East Eosinophilic Asthma Market Overview

28.2. Middle East Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Eosinophilic Asthma Market

29.1. Africa Eosinophilic Asthma Market Overview

29.2. Africa Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Eosinophilic Asthma Market Competitive Landscape And Company Profiles

30.1. Eosinophilic Asthma Market Competitive Landscape

30.2. Eosinophilic Asthma Market Company Profiles

30.2.1. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

30.2.4. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Eosinophilic Asthma Market Other Major And Innovative Companies

31.1. GSK plc

31.2. Amgen Inc.

31.3. Viatris Inc.

31.4. Teva Pharmaceutical Industries Limited

31.5. Boehringer Ingelheim GmbH

31.6. Regeneron Pharmaceuticals Inc.

31.7. Chiesi Farmaceutici S.p.A.

31.8. Company 13

31.9. Company 14

31.10. Company 15

31.11. Company 16

31.12. Company 17

31.13. Company 18

31.14. Company 19

31.15. Company 20

32. Global Eosinophilic Asthma Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Eosinophilic Asthma Market

34. Recent Developments In The Eosinophilic Asthma Market

35. Eosinophilic Asthma Market High Potential Countries, Segments and Strategies

35.1 Eosinophilic Asthma Market In 2029 - Countries Offering Most New Opportunities

35.2 Eosinophilic Asthma Market In 2029 - Segments Offering Most New Opportunities

35.3 Eosinophilic Asthma Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Eosinophilic Asthma Market, Sub-Segmentation Of Severe Eosinophilic Asthma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Eosinophilic Asthma Market, Sub-Segmentation Of Mild To Moderate Eosinophilic Asthma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Eosinophilic Asthma Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Eosinophilic Asthma Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Asia-Pacific, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Asia-Pacific, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: China, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: China, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: India, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: India, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: Japan, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: Japan, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Australia, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Australia, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Indonesia, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Indonesia, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: South Korea, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: South Korea, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: Western Europe, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Western Europe, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: UK, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: UK, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: Germany, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Germany, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: France, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: France, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: Italy, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: Italy, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Spain, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Spain, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Eastern Europe, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Eastern Europe, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Russia, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Russia, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: North America, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: North America, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: USA, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: USA, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: Canada, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: Canada, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: South America, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: South America, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: Brazil, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: Brazil, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Middle East, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Middle East, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Africa, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Africa, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Roche Holding AG Financial Performance

Table 77: Sanofi S.A. Financial Performance

Table 78: Bristol-Myers Squibb Company Financial Performance

Table 79: AstraZeneca plc Financial Performance

Table 80: Novartis AG Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Eosinophilic Asthma Market, Sub-Segmentation Of Severe Eosinophilic Asthma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Eosinophilic Asthma Market, Sub-Segmentation Of Mild To Moderate Eosinophilic Asthma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Eosinophilic Asthma Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Eosinophilic Asthma Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Asia-Pacific, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Asia-Pacific, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: China, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: China, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: India, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: India, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: Japan, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: Japan, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Australia, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Australia, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Indonesia, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Indonesia, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: South Korea, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: South Korea, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: Western Europe, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Western Europe, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: UK, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: UK, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: Germany, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Germany, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: France, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: France, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: Italy, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: Italy, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Spain, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Spain, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Eastern Europe, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Eastern Europe, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Russia, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Russia, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: North America, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: North America, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: USA, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: USA, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: Canada, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: Canada, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: South America, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: South America, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: Brazil, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: Brazil, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Middle East, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Middle East, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Africa, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Africa, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Roche Holding AG Financial Performance

Figure 77: Sanofi S.A. Financial Performance

Figure 78: Bristol-Myers Squibb Company Financial Performance

Figure 79: AstraZeneca plc Financial Performance

Figure 80: Novartis AG Financial Performance

From Insight to Impact: Strategic Growth Mapping in the HER2-Positive Breast Cancer Market

Hospital And Nursing Home Probiotics Market Overview 2025: Competitive Shifts, Forecast Models, and Emerging Opportunities

Next-Gen Implantable Cardioverter Defibrillators (ICDs) : Market Forecast, Transformation, and Long-Term Trajectories

Indwelling Catheters Growth Trajectory: Key Forecasts and Strategic Insights

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Explore the latest trends, growth insights, and forecasts in the Nutrition Analysis Software Global Market.

Corticosteroids Global Market Report 2025 – By Product (Glucocorticoids, Mineralocorticoids), By Application (Skin Allergies, Rheumatology Indications, Endocrinology, Acute Respiratory Diseases, Other Applications), By E...

Asthma Spacers Global Market Report 2025 – By Product (Aerochamber, Optichamber, Volumatic, Inspirease, Other Products), By Distribution Channels (E-commerce Channels, Retail Pharmacies, Hospital Pharmacies, Other Distri...

Allergic Rhinitis Drugs Global Market Report 2025 – By Disease (Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis, Occupational Allergic Rhinitis), By Treatment (Antihistamines, Immunotherapy, Corticosteroids, Deco...

Intelligent Asthma Monitoring Devices Global Market Report 2025 – By Product (Wearable Asthma Monitoring Devices, Smart Inhalers, Inhalers, Dry Powdered Inhalers, Metered Dose Inhalers, Nebulizers), By Technology (Manual...

Asthma Drugs Global Market Report 2025 – By Type Of Asthma (Allergic, Non-Allergic), By Asthma Trigger Type (Adult-Onset Asthma, Child-Onset Asthma, Cough-Induced Asthma, Exercise-Induced Asthma, Occupational Asthma, Noc...

Anti-Asthmatic And COPD Drugs Market 2021 - By Drug Class (Bronchodilators, Monoclonal Antibodies, Anti-Inflammatory Drugs, Combination Drugs), By End User (Asthma Patients, COPD Patients), By Distribution Channel (Gener...

Frequently Asked Questions

What is the definition of the Eosinophilic Asthma market?

How will the Eosinophilic Asthma market drivers and restraints affect the market dynamics? What forces will shape the Eosinophilic Asthma industry going forward?

The market major growth driver - Impact Of Rising Smoking Habits On The Growth Of The Market. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Eosinophilic Asthma market?

The eosinophilic asthma market size has grown rapidly in recent years. It will grow from $2.69 billion in 2024 to $3.16 billion in 2025 at a compound annual growth rate (CAGR) of 17.4%. The growth in the historic period can be attributed to increase in pollution, lower immunity in population, rise in prevalence of eosinophilic asthma, increase in prevalence of allergens and respiratory conditions, rise in healthcare expenditure, and rise in R&D activities. The eosinophilic asthma market size is expected to see rapid growth in the next few years. It will grow to " $5.95 billion in 2029 at a compound annual growth rate (CAGR) of 17.1%. The growth in the forecast period can be attributed to increasing prevalence of respiratory diseases, rising awareness and diagnosis rates, expanding therapeutic indications for monoclonal antibodies, growing investment in healthcare infrastructure, and the rising personalized medicine approaches. Major trends in the forecast period include development of targeted biologics, improved diagnostic tools, personalized treatment approaches, enhanced drug delivery systems, integration of digital health technologies, and expanded clinical trials for novel therapies. For further insights on this market, request a sample here

How is the Eosinophilic Asthma market segmented?

The eosinophilic asthmamarket covered in this report is segmented –
1) By Disease: Severe Eoisnophilic Asthma; Mild To Moderate Eosinophilic Asthma
2) By Treatment: Biologics; Bronchodilators; Corticosteroids; Immunomodulators; Other Treatments
3) By End User: Hospitals; Clinics; Other End Users Subsegments:
1) By Severe Eosinophilic Asthma: Refractory Eosinophilic Asthma; Late-Onset Eosinophilic Asthma
2) By Mild To Moderate Eosinophilic Asthma: Early-Onset Eosinophilic Asthma; Intermittent Eosinophilic Asthma For further insights on this market, request a sample here

Which region has the largest share of the Eosinophilic Asthma market? What are the other regions covered in the report?

North America was the largest region in the eosinophilic asthma market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the eosinophilic asthma market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Who are the major players in the Eosinophilic Asthma market?

What are the key trends in the Eosinophilic Asthma market?

Major trends in this market include Advancements In Targeted Therapies For Severe Asthma Management. For further insights on this market, request a sample here.